Stocks
Humana Financial Statements (HUM) |
||||||||||
| Humanasmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 20.02.2020 | 18.02.2021 | 17.02.2022 | 16.02.2023 | 15.02.2024 | 30.10.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 64 888 | 77 155 | 83 064 | 92 870 | 106 374 | 115 010 | |||
| Operating Income, bln rub | 3 712 | 4 957 | 3 745 | 3 800 | 4 013 | 2 617 | ||||
| EBITDA, bln rub | ? | 4 170 | 5 446 | 4 340 | 4 678 | 4 930 | 3 766 | |||
| Net profit, bln rub | ? | 2 707 | 3 367 | 2 933 | 2 806 | 2 489 | 1 359 | |||
| OCF, bln rub | ? | 5 284 | 5 639 | 2 262 | 4 587 | 3 981 | -3 640 | |||
| CAPEX, bln rub | ? | 736.0 | 964.0 | 1 316 | 1 120 | 1 004 | 704.0 | |||
| FCF, bln rub | ? | 4 548 | 4 675 | 946.0 | 3 467 | 2 977 | -4 344 | |||
| Dividend payout, bln rub | 291.0 | 323.0 | 354.0 | 392.0 | 431.0 | 434.0 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 10.7% | 9.59% | 12.1% | 14.0% | 17.3% | 31.9% | ||||
| OPEX, bln rub | 61 176 | 72 198 | 79 319 | 89 070 | 102 361 | 87 422 | ||||
| Cost of production, bln rub | 7 381 | 10 052 | 10 121 | 12 671 | 13 188 | 13 356 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 242.0 | 283.0 | 326.0 | 401.0 | 493.0 | 642.0 | ||||
| Assets, bln rub | 29 074 | 34 969 | 44 358 | 43 055 | 47 065 | 50 007 | ||||
| Net Assets, bln rub | ? | 12 037 | 13 728 | 16 080 | 15 311 | 16 262 | 17 565 | |||
| Debt, bln rub | 5 891 | 6 980 | 12 820 | 11 424 | 11 656 | 13 022 | ||||
| Cash, bln rub | 4 054 | 4 673 | 3 394 | 5 061 | 21 320 | 24 149 | ||||
| Net debt, bln rub | 1 837 | 2 307 | 9 426 | 6 363 | -9 664 | -11 127 | ||||
| Ordinary share price, rub | 366.5 | 410.3 | 463.9 | 512.2 | 457.8 | 481.1 | ||||
| Number of ordinary shares, mln | 134.1 | 132.2 | 128.7 | 126.4 | 123.9 | 120.4 | ||||
| Market cap, bln rub | 49 134 | 54 237 | 59 693 | 64 751 | 56 707 | 57 926 | ||||
| EV, bln rub | ? | 50 971 | 56 544 | 69 119 | 71 114 | 47 043 | 46 799 | |||
| Book value, bln rub | 7 932 | 8 952 | 2 349 | 4 404 | 5 019 | 7 975 | ||||
| EPS, rub | ? | 20.2 | 25.5 | 22.8 | 22.2 | 20.1 | 11.3 | |||
| FCF/share, rub | 33.9 | 35.4 | 7.35 | 27.4 | 24.0 | -36.1 | ||||
| BV/share, rub | 59.2 | 67.7 | 18.3 | 34.8 | 40.5 | 66.2 | ||||
| EBITDA margin, % | ? | 6.43% | 7.06% | 5.22% | 5.04% | 4.63% | 3.27% | |||
| Net margin, % | ? | 4.17% | 4.36% | 3.53% | 3.02% | 2.34% | 1.18% | |||
| FCF yield, % | ? | 9.26% | 8.62% | 1.58% | 5.35% | 5.25% | -7.50% | |||
| ROE, % | ? | 22.5% | 24.5% | 18.2% | 18.3% | 15.3% | 7.74% | |||
| ROA, % | ? | 9.31% | 9.63% | 6.61% | 6.52% | 5.29% | 2.72% | |||
| P/E | ? | 18.2 | 16.1 | 20.4 | 23.1 | 22.8 | 42.6 | |||
| P/FCF | 10.8 | 11.6 | 63.1 | 18.7 | 19.0 | -13.3 | ||||
| P/S | ? | 0.76 | 0.70 | 0.72 | 0.70 | 0.53 | 0.50 | |||
| P/BV | ? | 6.19 | 6.06 | 25.4 | 14.7 | 11.3 | 7.26 | |||
| EV/EBITDA | ? | 12.2 | 10.4 | 15.9 | 15.2 | 9.54 | 12.4 | |||
| Debt/EBITDA | 0.44 | 0.42 | 2.17 | 1.36 | -1.96 | -2.95 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 1.13% | 1.25% | 1.58% | 1.21% | 0.94% | 0.61% | ||||
| Humana shareholders | ||||||||||
